By Reuters
NYT Business Day
Eli Lilly and Co on Tuesday reported lower-than-expected first-quarter sales for its top-selling diabetes drug Trulicity, saying they were partly hurt by programs that allow patients to try newer drugs at little or no cost to them as insurance com...
Published date: April 30, 2019 at 02:01PM
Reuters
New York Times article
No comments:
Post a Comment